Invesco S&P Midcap 400 Pure Growth ETF (RFG)
| Assets | $280.89M |
| Expense Ratio | 0.35% |
| PE Ratio | 19.64 |
| Shares Out | 6.25M |
| Dividend (ttm) | $0.15 |
| Dividend Yield | 0.34% |
| Ex-Dividend Date | Mar 24, 2025 |
| Payout Ratio | 6.61% |
| 1-Year Return | -13.55% |
| Volume | 11,338 |
| Open | 42.64 |
| Previous Close | 43.84 |
| Day's Range | 42.64 - 43.96 |
| 52-Week Low | 42.64 |
| 52-Week High | 53.78 |
| Beta | 1.15 |
| Holdings | 93 |
| Inception Date | Mar 1, 2006 |
About RFG
Fund Home PageThe Invesco S&P Midcap 400 Pure Growth ETF (RFG) is an exchange-traded fund that is based on the S&P Mid Cap 400 Pure Growth index. The fund tracks a factor-weighted index of the S&P 400 companies exhibiting the strongest growth factors. RFG was launched on Mar 1, 2006 and is issued by Invesco.
Top 10 Holdings
18.70% of assets| Name | Symbol | Weight |
|---|---|---|
| Roivant Sciences Ltd. | ROIV | 2.21% |
| Carpenter Technology Corporation | CRS | 2.17% |
| Valaris Limited | VAL | 2.01% |
| Hims & Hers Health, Inc. | HIMS | 2.00% |
| Globus Medical, Inc. | GMED | 1.91% |
| RenaissanceRe Holdings Ltd. | RNR | 1.70% |
| Shift4 Payments, Inc. | FOUR | 1.70% |
| Exelixis, Inc. | EXEL | 1.69% |
| Masimo Corporation | MASI | 1.68% |
| Halozyme Therapeutics, Inc. | HALO | 1.65% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 24, 2025 | $0.03309 | Mar 28, 2025 |
| Dec 23, 2024 | $0.02827 | Dec 27, 2024 |
| Sep 23, 2024 | $0.03531 | Sep 27, 2024 |
| Jun 24, 2024 | $0.05086 | Jun 28, 2024 |
| Mar 18, 2024 | $0.06887 | Mar 22, 2024 |
| Dec 18, 2023 | $0.12153 | Dec 22, 2023 |
News
RFG: A Pure Play On Mid-Cap Growth
Invesco S&P MidCap 400® Pure Growth ETF is a fund focusing on mid-cap growth stocks, offering exposure to a selection of US midcap equity stocks with growth characteristics. The RFG fund tracks the S&...
RFG: Investors Should Consider Disadvantages Carefully
RFG deploys a pure-growth strategy in the mid-cap universe only to end up being overweight in large caps. That is certainly not a fundamental, intolerable flaw, yet this is nonetheless a facet SMID in...
Reasons For Midstream Investors To Be Calm Amid Today's Stock Market Storm
Oil and gas midstream stocks are not E&Ps, though they're trading as if they were. Oil macro conditions will remain positive for midstream above $70 per barrel.
An Interesting Opportunity Is Brewing With Mid-Cap ETFs
Among the many asset classes that performed well in the first quarter were mid-cap stocks. In the first three months of the year, the S&P MidCap 400 Index returned 14.8 percent, beating the S&P 500 by...